Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer by Himani Aggarwal, Yimei Han, Kristin M Sheffield, Zhanglin Lin Cui

Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States by Lisa M. Hess, Yimei Han, Yajun Emily Zhu, Naleen Raj Bhandari, Anthony Sireci

Get full text

Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States by Lisa M. Hess, Yimei Han, Yajun Emily Zhu, Naleen Raj Bhandari, Anthony Sireci

Get full text

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021 by Lisa M. Hess, PhD, Peter M. Krein, PhD, Diane Haldane, MS, Yimei Han, MS, Anthony N. Sireci, MD

Get full text

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001 by Filippo De Braud, Barbara Deschler-Baier, John C. Morris, Francis Worden, Yimei Han, Urpo Kiiskinen, Min-Hua Jen, Scott S. Barker, Sylwia Szymczak, Adrienne M. Gilligan

Get full text